CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ERAS — Erasca, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ERAS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$30,713,264
+$24,488,202 QoQ
Shares Held
1,898,224
+13.4% QoQ
Ownership
0.610%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. ERAS ranks #43 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in ERAS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,713,264 | 1,898,224 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,225,062 | 1,673,404 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,761,276 | 1,725,356 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,154,673 | 1,696,593 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,975,068 | 1,441,656 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $4,424,366 | 1,762,696 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,705,509 | 1,723,630 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,146,873 | 1,333,421 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,367,572 | 663,870 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,384,787 | 650,135 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,264,028 | 641,639 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,602,726 | 580,698 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,652,754 | 549,088 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,956,765 | 454,006 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,492,645 | 447,775 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,267,626 | 227,581 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,062,606 | 239,838 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,189,395 | 140,526 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,830,641 | 133,395 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||